Inventor · disambiguated record
Kalyana Chakravarthi Dulla
Also filed as: DULLA KALYANA CHAKRAVARTHI
3 granted patents·4 pending applications·0 citations·filing 2012–2024
45Inventor score
Top patents by PatentIndex Score
7 records- 0168US2025333734A1Antisense oligonucleotides for the treatment of Stargardt diseasePROQR THERAPEUTICS II BV·Filed 2024·Application pending·0 cites
- 0268US2023105263A1Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expressionINNOSIGN B V·Filed 2022·Application pending·0 cites
- 0355US12180471B2Antisense oligonucleotides for the treatment of Stargardt diseasePROQR THERAPEUTICS II BV·Filed 2018·Granted Dec 31, 2024·0 cites·5 claims
- 0455US11443831B2Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expressionVERHAEGH WILHELMUS FRANCISCUS JOHANNES·Filed 2012·Granted Sep 13, 2022·0 cites·7 claims
- 0552US12398393B2RNA-editing oligonucleotides for the treatment of usher syndromePROQR THERAPEUTICS II BV·Filed 2020·Granted Aug 26, 2025·0 cites·15 claims
- 0644US2022213478A1Antisense oligonucleotides for the treatment of usher syndromePROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 0740US2022098584A1Antisense oligonucleotides for the treatment of leber`s congenital amaurosisPROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kalyana Chakravarthi Dulla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →